Shilajit and testosterone — the trial is real, but it tested a purified extract, not the resin
Our usual finding with a viral supplement is that the claim outruns the evidence. Shilajit is the rarer case: the anchor trial holds up. The problem is not the molecule — it's what's being sold.
What the trial actually found
Pandit 2016 (Andrologia, PMID 26395129) was randomised, double-blind and placebo-controlled. Healthy men aged 45–55 took purified shilajit at 250 mg twice a day for 90 consecutive days. Total testosterone rose roughly 20%, free testosterone about 19%, and DHEAS about 31% versus placebo — with LH and FSH "well maintained." For a plant-derived supplement, that's an unusually clean result.
The catch is the product, not the molecule
That trial used a standardised, purity-tested extract. The raw resin trending on social media is a different thing.
We put the full breakdown — every study, every number, with the PMIDs — on our own site.
Originally published at super-achiever.com. We check viral supplement claims against the primary research and publish the results — including the ones that go against us.